Deerfield Management’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-950,000
Closed -$764K 123
2020
Q2
$764K Hold
950,000
0.02% 91
2020
Q1
$656K Buy
+950,000
New +$1.16M 0.02% 87
2016
Q2
Sell
-56,990
Closed -$4.76M 124
2016
Q1
$4.76M Buy
+56,990
New +$4.7M 0.2% 72
2015
Q4
Sell
-234,711
Closed -$28.8M 137
2015
Q3
$28.8M Sell
234,711
-10,279
-4% -$1.4M 1.11% 34
2015
Q2
$37.6M Buy
244,990
+10,055
+4% +$1.66M 1.25% 26
2015
Q1
$40.1M Sell
234,935
-102,944
-30% -$15.6M 1.3% 21
2014
Q4
$51.7M Buy
337,879
+87,726
+35% +$10.9M 1.86% 18
2014
Q3
$26.5M Buy
250,153
+101,960
+69% +$14.2M 0.97% 35
2014
Q2
$22.5M Buy
148,193
+79,847
+117% +$10.6M 0.91% 39
2014
Q1
$8.8M Buy
+68,346
New +$10.6M 0.36% 69

Other funds holding ELGX

Deerfield Management's ELGX Position: Q3 2020 in Review

Deerfield Management sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 950,000 shares — an estimated $764K sold.

Deerfield Management first reported a position in ELGX in Q1 2014 and held it in 10 quarters. The position peaked at $51.7M in Q4 2014. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.

  • Deerfield Management reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
  • Deerfield Management sold 950,000 Endologix Inc shares in Q3 2020, an estimated $764K.
  • Deerfield Management first reported a position in Endologix Inc in Q1 2014 and held it in 10 quarters.
  • Deerfield Management's Endologix Inc position peaked at $51.7M in Q4 2014.
  • 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.

Based on Deerfield Management's 13F filing for Q3 2020, filed 16 Nov 2020.